UK markets open in 6 hours 3 minutes

Navidea Biopharmaceuticals, Inc (NAVB)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0376+0.0001 (+0.27%)
At close: 02:23PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0.61
14.645
45.615
118.725
Cost of revenue
50.036
184.947
0
1.048
Gross profit
-49.426
-170.302
45.615
117.677
Operating expenses
Research development
5,093
5,970
5,142
4,930
Selling general and administrative
5,037
7,962
7,450
6,695
Total operating expenses
10,130
13,881
12,106
10,829
Operating income or loss
-10,180
-14,051
-12,060
-10,711
Interest expense
-
1,098
6.361
-
Total other income/expenses net
1,569
-27.939
351.885
-21.854
Income before tax
-8,607
-15,177
-11,715
-10,722
Income tax expense
-
0
16.043
0
Income from continuing operations
-8,607
-15,177
-11,731
-10,722
Net income
-1,182
-15,177
-11,731
-10,722
Net income available to common shareholders
-1,389
-17,215
-11,731
-11,386
Basic EPS
-0.08
-0.56
-0.40
-0.48
Diluted EPS
-0.08
-0.56
-0.40
-0.48
Basic average shares
53,347
30,902
29,344
23,896
Diluted average shares
53,347
30,902
29,344
23,896